Norflurazepam Blister – 10x 5mg

A. Introduction

Norflurazepam Blister 10x 5mg is a premium laboratory-grade research chemical containing the benzodiazepine metabolite analog N-desalkylflurazepam, designed for scientific institutions and analytical laboratories investigating long-acting benzodiazepine standards. This high-purity blister format provides researchers with consistent 5mg units for method validation, structural analysis, and multi-point calibration curves in controlled settings.

B. Scientific Overview

Norflurazepam (N-desalkylflurazepam) belongs to the 1,4-benzodiazepine class as an active metabolite of flurazepam and related compounds, characterized by its desalkylated benzodiazepine scaffold suitable for analytical profiling. In research contexts, it functions as an analytical reference for studying chromatographic behavior, mass spectrometry fragmentation patterns, and spectroscopic signatures of long-acting benzodiazepine metabolites.

Laboratory investigations focus on its chemical properties, including extended elimination profiles, protein binding characteristics, and stability under analytical conditions, without reference to biological interactions.

C. Product Specifications

• Form: Blister-packed units containing 5mg norflurazepam per tablet (10 tablets per pack)
• Label per unit: 5mg analytical portions in tamper-evident blister packaging
• Synonym: N-Desalkylflurazepam, Norflurazepam
• CAS Number: 2792-23-8
• Molecular Formula: C₁₅H₁₁ClFN₃O
• Molecular Weight: 303.72 g/mol
• Purity: ≥98% (HPLC, typical batch purity)
• Storage Conditions: Cool, dry place (2-8°C recommended), protected from light/moisture for stability

D. Laboratory Use Context

Norflurazepam Blister 10x 5mg is designated solely for in-vitro analytical research, including multi-point reference standard preparation, LC-MS/MS method optimization for benzodiazepine metabolites, forensic toxicology screening, and therapeutic drug monitoring validation.

Researchers apply it in controlled environments for quantitative analysis across therapeutic ranges, positive ionization studies ([M+H]+), and stability testing via HPLC/UV protocols. The blister format ensures sample integrity for replicate analyses and long-term stability studies.

E. Quality & Testing

Every batch receives comprehensive quality control:

• Certificate of Analysis (COA) with HPLC, MS, NMR identity confirmation and uniformity testing
• Full batch traceability from synthesis through blister packaging and verification
• Third-party laboratory testing for purity, content uniformity, dissolution profile, and residual solvents
• Manufactured under controlled conditions ensuring consistent tablet performance and stability

F. Shipping & Handling

Discreet worldwide shipping to verified research laboratories via secure, compliant carriers. Blister packaging provides inherent protection meeting IATA/DOT standards for benzodiazepine research chemicals, with full documentation for customs clearance. Tracking provided; buyers confirm jurisdictional import compliance prior to purchase.

G. Compliance Disclaimer

For Research Use Only. Not for human consumption.
This product is supplied strictly as a laboratory reagent for analytical purposes. It is not approved for human, veterinary, diagnostic, or therapeutic applications. No statements imply biological effects beyond in-vitro research contexts.

Qualified researchers and institutions assume full responsibility under local, federal, and international laws. Seller disclaims all liability for non-research use. Consult safety data sheets and institutional protocols before handling.